Literature DB >> 23458588

Estimated glomerular filtration rate reversal by blood pressure lowering in chronic kidney disease: Japan Multicenter Investigation for Cardiovascular DiseaseB CKD study.

Yoshiki Yui1, Kazuhisa Kodama, Atsushi Hirayama, Saichi Hosoda, Chuichi Kawai.   

Abstract

Patients are diagnosed as having chronic kidney disease (CKD) if estimated glomerular filtration rate (eGFR) is <60 mL/min/1.73 m(2) . Low eGFR is likely to increase the incidence of cardiovascular events and lead to dialysis. Therefore, it is important to prevent eGFR from decreasing eGFR. However, it still remains unknown whether antihypertensive therapy can prevent low eGFR from becoming even lower and improve eGFR in hypertensive patients with CKD. The authors analyzed the results of the Japan Multicenter Investigation for Cardiovascular DiseaseB (JMIC-B) and investigated the effects of antihypertensive therapy on eGFR. In hypertensive patients with CKD (eGFR <60), eGFR was significantly increased from 51.87±6.21 (n=98) to 57.55±19.00 (P<.001) after 3 years of antihypertensive therapy. In patients without CKD (eGFR ≥60), eGFR was significantly decreased from 91.84±23.27 (n=682) to 88.95±23.67 (P<.001). Regardless of the type of antihypertensive drugs used, eGFR was significantly increased in patients with CKD and was significantly decreased in patients without CKD. This paper shows that antihypertensive therapy can improve eGFR in hypertensive patients with CKD. J Clin Hypertens (Greenwich). 2012;00:00-00. ©2012 Wiley Periodicals, Inc.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23458588      PMCID: PMC8033949          DOI: 10.1111/jch.12054

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  18 in total

1.  Kidney function can improve in patients with hypertensive CKD.

Authors:  Bo Hu; Crystal Gadegbeku; Michael S Lipkowitz; Stephen Rostand; Julia Lewis; Jackson T Wright; Lawrence J Appel; Tom Greene; Jennifer Gassman; Brad C Astor
Journal:  J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 10.121

Review 2.  Renal dysfunction complicating the treatment of hypertension.

Authors:  Biff F Palmer
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

3.  Quantitative coronary angiogram analysis: nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B side arm study).

Authors:  Eiji Shinoda; Yoshiki Yui; Kazuhisa Kodama; Atsushi Hirayama; Hiroshi Nonogi; Kazuo Haze; Tetsuya Sumiyoshi; Saichi Hosoda; Chuichi Kawai
Journal:  Hypertension       Date:  2005-04-25       Impact factor: 10.190

4.  Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  S Moe; T Drüeke; J Cunningham; W Goodman; K Martin; K Olgaard; S Ott; S Sprague; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

5.  Long-term improvement in renal function after short-term strict blood pressure control in hypertensive nephrosclerosis.

Authors:  W A Pettinger; H C Lee; J Reisch; H C Mitchell
Journal:  Hypertension       Date:  1989-06       Impact factor: 10.190

6.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

7.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

Authors:  Nagesh S Anavekar; John J V McMurray; Eric J Velazquez; Scott D Solomon; Lars Kober; Jean-Lucien Rouleau; Harvey D White; Rolf Nordlander; Aldo Maggioni; Kenneth Dickstein; Steven Zelenkofske; Jeffrey D Leimberger; Robert M Califf; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

8.  Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease.

Authors:  Yoshiki Yui; Kazuhisa Kodama; Atsushi Hirayama; Ryosuke Nishio; Yoshitaka Iwanaga; Hiroshi Nonogi; Kazuo Haze; Tetsuya Sumiyoshi; Natsuko Yui; Saichi Hosoda; Chuichi Kawai
Journal:  J Hypertens       Date:  2010-01       Impact factor: 4.844

9.  Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy).

Authors:  Yoshiki Yui; Eiji Shinoda; Kazuhisa Kodama; Atsushi Hirayama; Hiroshi Nonogi; Kazuo Haze; Tetsuya Sumiyoshi; Saichi Hosoda; Chuichi Kawai
Journal:  J Hypertens       Date:  2007-10       Impact factor: 4.844

10.  Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.

Authors:  James Shepherd; John J P Kastelein; Vera Bittner; Prakash Deedwania; Andrei Breazna; Stephen Dobson; Daniel J Wilson; Andrea Zuckerman; Nanette K Wenger
Journal:  Clin J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 8.237

View more
  1 in total

1.  Clinical and pathological analysis of the kidney in patients with hypertensive nephropathy.

Authors:  Xiang-Chuan Wang; Chun-Hui Liu; Yun-Jing Chen; Yang Wu; Lei-Shan Yang; Hong-Min Liu; Hai-Li Liao
Journal:  Exp Ther Med       Date:  2013-09-18       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.